Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PERPHENAZINE FOR SYSTEM SUITABILITY CRS (5 MG)

PERPHENAZINE FOR SYSTEM SUITABILITY CRS (5 MG)

58-39-9

DISCOVER
SEVOFLURANE CRS (0.5 ML)

SEVOFLURANE CRS (0.5 ML)

28523-86-6

DISCOVER
TEICOPLANIN FOR IDENTIFICATION CRS (50 MG)

TEICOPLANIN FOR IDENTIFICATION CRS (50 MG)

61036-62-2

DISCOVER
LEVODROPROPIZINE IMPURITY C CRS (420 MG)

LEVODROPROPIZINE IMPURITY C CRS (420 MG)

556-52-5

DISCOVER
SAQUINAVIR MESILATE CRS (70 MG)

SAQUINAVIR MESILATE CRS (70 MG)

149845-06-7

DISCOVER
ST. JOHN'S WORT DRY EXTRACT HRS (1020 MG)

ST. JOHN'S WORT DRY EXTRACT HRS (1020 MG)

84082-80-4

DISCOVER
PENTETATE SODIUM CALCIUM CRS (100 MG)

PENTETATE SODIUM CALCIUM CRS (100 MG)

12111-24-9

DISCOVER
SANTONIN CRS (25 MG)

SANTONIN CRS (25 MG)

481-06-1

DISCOVER
CROSPOVIDONE CRS (25 MG)

CROSPOVIDONE CRS (25 MG)

9003-39-8

DISCOVER
CELLULOSE ACETATE PHTHALATE CRS (10 MG)

CELLULOSE ACETATE PHTHALATE CRS (10 MG)

9004-38-0

DISCOVER
TRIBUTYL ACETYLCITRATE CRS (1ML)

TRIBUTYL ACETYLCITRATE CRS (1ML)

77-90-7

DISCOVER
SAQUINAVIR FOR SYSTEM SUITABILITY CRS (0.3033 MG)

SAQUINAVIR FOR SYSTEM SUITABILITY CRS (0.3033 MG)

149845-06-7

DISCOVER